| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.1B | $7.6B | $8.9B | $7.9B | $6.8B | $7.0B | $8.2B | $7.1B |
| Cost of Revenue | $7.4B | $6.9B | $8.2B | $7.2B | $6.2B | $6.4B | $7.6B | $6.6B |
| Gross Profit | $0.7B | $0.6B | $0.7B | $0.6B | $0.6B | $0.5B | $0.6B | $0.5B |
| R&D Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.3B | $0.3B |
| Operating Income | $0.4B | $0.3B | $0.5B | $0.4B | $0.3B | $0.2B | $0.3B | $0.1B |
| Net Income | $0.2B | $0.2B | $0.3B | $0.3B | $0.3B | $0.1B | $0.1B | $-0.1B |
| EPS (Basic) | $4.56 | $4.00 | $5.36 | $4.18 | $4.12 | $2.02 | $2.05 | $-1.37 |
| EPS (Diluted) | $4.46 | $3.91 | $5.18 | $4.06 | $4.01 | $1.97 | $1.97 | $-1.37 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.9B | $4.8B | $4.9B | $4.9B | $4.2B | $3.8B | $3.9B | $4.1B |
| Current Assets | $4.9B | $3.9B | $3.9B | $3.9B | $3.3B | $2.8B | $2.9B | $3.0B |
| Cash & Equivalents | $0.9B | $0.6B | $0.7B | $0.5B | $0.7B | $0.5B | $0.5B | $0.4B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $2.8B | $1.9B | $2.0B | $2.5B | $1.8B | $1.5B | $1.7B | $2.4B |
| Stockholders' Equity | — | — | — | $1.9B | $1.9B | $1.6B | $1.6B | $1.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.3B | $0.2B | $0.3B | $0.3B | $0.3B | $0.4B | $0.2B |
| Investing Cash Flow | $-0.1B | $-0.1B | $-0.2B | $-0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.1B |
| Capital Expenditures | $0.1B | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.2B | $-0.3B | $0.1B | $-0.3B | $-0.1B | $-0.2B | $-0.2B | $-0.0B |